Characterizes anti-interferon antibodies in NMDAR encephalitis, suggesting involvement in disease mechanisms.
To characterize the presence of neutralizing antibodies against interferon-omega (IFN-ω) in cerebrospinal fluid (CSF) and serum from patients with NMDA receptor (NMDAR) encephalitis as an approach to establish disease mechanisms.
No takes yet. Share an insight, caveat, or question.
Hernandez et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: